{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:22:08Z","timestamp":1784132528621,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.healun.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T20:46:55Z","timestamp":1637700415000},"page":"174-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-1805","authenticated-orcid":false,"given":"Hoong Sern","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3793-407X","authenticated-orcid":false,"given":"Alexander W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-3910","authenticated-orcid":false,"given":"Sahan","family":"Jayawardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Mossialos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-7044","authenticated-orcid":false,"given":"Mandeep R.","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.11.014_bib0001","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0002","unstructured":"NICE. Chronic heart failure in adults: diagnosis and management. 2021. Accessed December 10, 2021. https:\/\/www.nice.org.uk\/guidance\/ng106"},{"key":"10.1016\/j.healun.2021.11.014_bib0003","series-title":"Acute Heart Failure: Diagnosis and Management","year":"2014"},{"key":"10.1016\/j.healun.2021.11.014_bib0004","first-page":"2021","article-title":"House of Commons. Quality of life for patients with heart failure","author":"Rough","year":"2021","journal-title":"Number CDP"},{"key":"10.1016\/j.healun.2021.11.014_bib0005","unstructured":"NHS Digital. Hospital admitted patient care activity, 2016-17. 2021. Accessed December 10, 2021. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-admitted-patient-care-activity\/2016-17"},{"key":"10.1016\/j.healun.2021.11.014_bib0006","unstructured":"NHS Digital. Hospital admitted patient care activity, 2019\/20. 2021. Accessed December 10, 2021. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-admitted-patient-care-activity\/2019-20"},{"key":"10.1016\/j.healun.2021.11.014_bib0007","unstructured":"Pumping Marvellous, Roche Diagnostics. The heart failure challenge. 2021. Accessed December 10, 2021. https:\/\/rochereport.readz.com\/the-heart-failurechallenge"},{"key":"10.1016\/j.healun.2021.11.014_bib0008","unstructured":"NICE. Resource impact report: chronic heart failure in adults: diagnosis and management (NG106); 2018"},{"key":"10.1016\/j.healun.2021.11.014_bib0009","unstructured":"NHS Digital. Hospital episode statistics database. 2021. Accessed December 10, 2021. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics"},{"key":"10.1016\/j.healun.2021.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40258-018-0439-x","article-title":"A systematic review of cost-effectiveness analyses of left ventricular assist devices: issues and challenges","volume":"17","author":"Schmier","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.healun.2021.11.014_bib0012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.athoracsur.2019.12.005","article-title":"The society of thoracic surgeons intermacs 2019 annual report: the changing landscape of devices and indications","volume":"109","author":"Teuteberg","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2021.11.014_bib0013","unstructured":"NHS England. 2013\/14 NHS standard contract for ventricular assist devices (VADs) as a bridge to heart transplantation or myocardial recovery (all ages). 2021. Accessed December 10, 2021. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/08\/Ventricular-assist-devices-as-a-bridge-to-heart-transplantation-or-myocardial-recovery-all-ages.pdf"},{"key":"10.1016\/j.healun.2021.11.014_bib0014","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.11.014_bib0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.0000139862.48167.23","article-title":"Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (randomized evaluation of mechanical assistance in treatment of chronic heart failure)","volume":"110","author":"Stevenson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.11.014_bib0016","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCHEARTFAILURE.113.000807","article-title":"Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure","volume":"7","author":"Long","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCHEARTFAILURE.111.962951","article-title":"Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy","volume":"5","author":"Rogers","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ejhf.1340","article-title":"Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable","volume":"21","author":"Mehra","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0019","first-page":"1","article-title":"Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure","volume":"19","year":"2004","journal-title":"Technol Eval Cent Assess Program Exec Summ"},{"key":"10.1016\/j.healun.2021.11.014_bib0020","unstructured":"NHS England. Making decisions about new treatments. 2019. Accessed December 10, 2021. https:\/\/www.england.nhs.uk\/commissioning\/spec-services\/"},{"key":"10.1016\/j.healun.2021.11.014_bib0021","unstructured":"NICE. The guidelines manual. 2021. Accessed December 10, 2021. https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/assessing-cost-effectiveness"},{"key":"10.1016\/j.healun.2021.11.014_bib0022","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2021.11.014_bib0023","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2021.11.014_bib0024","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.healun.2021.02.010","article-title":"Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study","volume":"40","author":"Pagani","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.11.014_bib0025","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.2211","article-title":"Primary results of long-term outcomes in the MOMENTUM-3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.healun.2021.11.014_bib0026","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","article-title":"Two-year outcomes with a magnetically levitated cardiac pump in heart failure","volume":"378","author":"Mehra","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.11.014_bib0027","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","volume":"5","author":"Goldstein","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.healun.2021.11.014_bib0028","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0029","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jchf.2018.03.019","article-title":"Ambulatory inotrope infusions in advanced heart failure: a systematic review and meta-analysis","volume":"6","author":"Nizamic","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0030","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.healun.2021.11.014_bib0031","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jchf.2017.02.016","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results","volume":"5","author":"Starling","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0032","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.healun.2018.09.021","article-title":"Outcomes with ambulatory advanced heart failure from the medical arm of mechanically assisted circulatory support (MedaMACS) registry","volume":"38","author":"Ambardekar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.11.014_bib0033","unstructured":"Office for National Statistics. English life tables No. 17. 2019. Accessed December 10, 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies\/datasets\/1englishlifetables"},{"key":"10.1016\/j.healun.2021.11.014_bib0034","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchf.2016.09.008","article-title":"Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure","volume":"5","author":"Baras Shreibati","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2021.11.014_bib0035","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.114.009985","volume":"130","author":"Cohen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2021.11.014_bib0036","first-page":"83","article-title":"Modelling the cost-effectiveness of cardiac interventions: the case of sirolimus-eluting stents","volume":"12","author":"Hawkins","year":"2005","journal-title":"Br J Cardiol (Acute Interv Cardiol)"},{"key":"10.1016\/j.healun.2021.11.014_bib0037","first-page":"1","volume":"17","author":"Sutcliffe","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.healun.2021.11.014_bib0038","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ejcts\/ezw054","article-title":"Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation","volume":"50","author":"Emin","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2021.11.014_bib0039","unstructured":"M Conolly, J Beattie, D Walker, M Dancy. End of life care in heart failure: a framework for implementation. 2019. Accessed December 10, 2021. https:\/\/www.england.nhs.uk\/improvement-hub\/wp-content\/uploads\/sites\/44\/2017\/11\/heart-failure.pdf."},{"key":"10.1016\/j.healun.2021.11.014_bib0040","unstructured":"Improvement. National tariff payment system. 2019. Accessed December 10, 2021. https:\/\/improvement.nhs.uk\/resources\/national-tariff\/"},{"key":"10.1016\/j.healun.2021.11.014_bib0041","unstructured":"NHS. 2018\/19 National cost collection data. 2021. Accessed December 10, 2021. https:\/\/www.england.nhs.uk\/national-cost-collection\/."},{"key":"10.1016\/j.healun.2021.11.014_bib0042","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2016.09.021","article-title":"The healthcare costs of heart failure during the last five years of life: a retrospective cohort study","volume":"224","author":"Hollingworth","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2021.11.014_bib0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/2396987317746516","article-title":"The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke","volume":"3","author":"Xu","year":"2018","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.healun.2021.11.014_bib0044","unstructured":"NHS. NHS prescription charges. Accessed December 10, 2021. https:\/\/www.nhs.uk\/nhs-services\/prescriptions-and-pharmacies\/nhs-prescription-charges\/"},{"key":"10.1016\/j.healun.2021.11.014_bib0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/heartjnl-2013-304598","article-title":"The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective","volume":"100","author":"Griffiths","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.healun.2021.11.014_bib0046","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.healun.2021.11.014_bib0047","unstructured":"NHS Blood and Transplant. 2020. Annual report on mechanical circulatory support related to heart transplantation report for 2019\/2020 (1 april 2010 \u201331 march 2020)"},{"key":"10.1016\/j.healun.2021.11.014_bib0048","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.healun.2020.03.002","article-title":"Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM-3 trial","volume":"39","author":"Patel","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.11.014_bib0049","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14737167.2017.1330152","article-title":"Recent amendments to NICE\u2019s value-based assessment of health technologies: implicitly inequitable?","volume":"17","author":"Paulden","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.healun.2021.11.014_bib0050","unstructured":"NICE. Consultation paper value based assessment of health technologies. Accessed December 10, 2021. https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/NICE-guidance\/NICE-technology-appraisals\/VBA-TA-Methods-Guide-for-Consultation.pdf"},{"key":"10.1016\/j.healun.2021.11.014_bib0051","unstructured":"CMS. National coverage determination for ventricular assist devices 20.9.1. Accessed December 10, 2021. https:\/\/www.cms.gov\/medicare-coverage-database\/details\/ncd-details.aspx?NCDId=360&ncdver=&NC1AId=298&type=Open&bc=ABAAAAAAIAAA&"},{"key":"10.1016\/j.healun.2021.11.014_bib0052","unstructured":"NHS England. NHS standard contract for ventricular assist devices as a bridge to heart transplantation or myocardial recovery. Accessed December 10, 2021. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/06\/a18-vad-all.pdf"},{"key":"10.1016\/j.healun.2021.11.014_bib0053","unstructured":"NHS England. Consultation on a policy proposition for long term left ventricular assist device therapy for advanced heart failure (all ages). 2019. Accessed December 10, 2021. https:\/\/www.engage.england.nhs.uk\/consultation\/long-term-left-ventricular-assist-device-therapy\/"},{"key":"10.1016\/j.healun.2021.11.014_bib0054","unstructured":"NIHR. Funding and awards. Left ventricular assist devices as destination therapy for advanced heart failure. Accessed December 10, 2021. https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR128996"},{"key":"10.1016\/j.healun.2021.11.014_bib0055","first-page":"1283","article-title":"Economic evaluation of left ventricular assist devices for patients with end stage heart failure who are ineligible for cardiac transplantation","volume":"33","author":"Chew","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2021.11.014_bib0056","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/ehf2.13401","article-title":"Cost-effectiveness of left ventricular assist devices as destination therapy in the United Kingdom","volume":"8","author":"Schueler","year":"2021","journal-title":"ESC Heart Fail"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821026115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821026115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:13:45Z","timestamp":1762355625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821026115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1053249821026115"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.11.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}